Reports
Reports
Sale
The global capsule endoscopy market size attained a value of USD 959.60 million in 2023, driven by rising health-related issues due to unhealthy eating habits and sedentary lifestyles of the major population and the increasing accessibility to healthcare in the developed countries. The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to attain a value of USD 2,033.10 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Capsule endoscopy is a diagnostic test that allows gastroenterologists to see into the gastrointestinal tract (GI) of a patient. The procedure involves swallowing a capsule fitted with a tiny camera, a transmitter, and a light. The capsule takes multiple pictures which are recorded and later visualized to detect any digestive tract-related issue. The market demand is significantly impacted by the rising prevalence of gastrointestinal diseases. It acts as a reliable screening method in numerous critical diseases such as colorectal cancer.
Colorectal cancer is the third most common type of cancer, accounting for 10% of all cancer cases. It is estimated that around 3.2 million new colorectal cancer cases will arise by 2040. Early detection of the cancer through capsule endoscopy can help in the successful treatment of the disease. With the rise in various gastrointestinal diseases and the heightened awareness among patients, the capsule endoscopy market share is anticipated to experience a surge in the coming years.
The rising healthcare expenditure is fuelling the demand for effective diagnostic procedures to screen chronic diseases. The market growth is also driven by the robust government support to improved healthcare services along with the growth in the approvals from health regulatory agencies such as the United States Food and Drug Administration (FDA). Furthermore, the evolving preference of patients for minimally invasive procedures, the increasing geriatric population size, and the introduction of technologically advanced endoscopy capsules in healthcare facilities are poised to boost market growth.
Surge in FDA Clearances to Meet Capsule Endoscopy Market Demand
There has been a significant surge in approvals by health regulatory bodies related to capsule endoscopy technology, which are projected to boost the market size in the forecast period. In January 2024 , AnX Robotica’s (a United States-based medical equipment manufacturing company) artificial intelligence (AI)-integrated reading tool received the United States Food and Drug Administration (FDA) clearance to assist in small bowel capsule endoscopy. The AI-assisted reading tool NaviCam ProScan, trained using over 150,000 images from 1,971 patients, can detect abnormal images and help in making well-informed clinical decisions for gastrointestinal bleeding cases. With a sensitivity of 99.88% in per-patient analysis, the NaviCam platform can significantly improve capsule endoscopy diagnostic workflows.
Rise in AI-integrated Novel Products
The technological advancements in endoscopy procedures through increasing artificial intelligence integration is one of the significant capsule endoscopy market trends. In July 2023 , Sheba Medical Center (Israel) entered a strategic partnership with Intel (a technology company headquartered in California) to develop an artificial intelligence algorithm that takes only minutes to analyze the images generated by the capsule endoscope. The application can assist physicians in selecting the best treatment options for Crohn’s disease patients and has the potential to reduce the risk of medical complications. The AI algorithm coupled with the capsule endoscopy has proved to be a highly effective diagnostic tool, carrying an accuracy of 86% in data and image analysis as compared to the 68% accuracy of an experienced gastroenterologist.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
Market Breakup by Type
Market Breakup by Component
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is a significant regional market for capsule endoscopy due to the rising cases of colon cancer in the region. The improvement in the healthcare sector supported by various initiatives and funding from the government is expected to augment the capsule endoscopy market growth. In January 2023 , Keck Hospital (University Hospital in California) and the School of Medicine of USC (University of Southern California) adopted tele-GI, a telehealth platform, which addressed the limitations of conventional gastrointestinal diagnostics. This innovative solution was developed in collaboration with GI Digital (a tele-GI company), leveraging capsule endoscopy to offer minimally invasive procedures. To support telehealth solutions and bring imaging technologies online, Keck Hospital and School of Medicine of USC was awarded USD 895,102 from FCC’s (Federal Communications Commission) telehealth grant program.
Asia Pacific is also anticipated to hold a significant capsule endoscopy market share in the coming years. The market growth can be attributed to a huge population size and the rising disease burden which is increasing the demand for effective screening procedures. In addition, technological advancement in capsule endoscopes and the growing focus of the government to improve healthcare facilities are expected to accelerate the market size.
In March 2023 , NexOptic Technology Corp., a Canada-based technology company specialised in developing artificial intelligence (AI) and imaging products signed a non-binding memorandum of understanding (MOU) with IntroMedic Co., Ltd (headquartered in South Korea), a medical device company known for its capsule endoscopy products. IntroMedic’s capsule endoscope MicroCam offers superior diagnostic capabilities with its 12-hour operational time and a 170-degree view of the digestive system. The collaboration aims to leverage NexOptics artificial intelligence-based imaging solutions to enhance image quality recorded during capsule endoscopy procedures and improve patient outcomes. Such strategic collaborations among the market players are expected to fuel the capsule endoscopy market growth in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Type |
|
Breakup by Component |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Capsule Endoscopy Market (2017-2032) Overview
3.1 Global Capsule Endoscopy Market (2017-2032) Historical Value (2017-2023)
3.2 Global Capsule Endoscopy Market (2017-2032) Forecast Value (2024-2032)
4 Global Capsule Endoscopy Market (2017-2032) Landscape
4.1 Global Capsule Endoscopy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Capsule Endoscopy Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Component
4.2.3 Analysis by Type
4.2.4 Analysis by Application
5 Global Capsule Endoscopy Market (2017-2032) Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Capsule Endoscopy Market (2017-2032) Segmentation
6.1 Global Capsule Endoscopy Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Small Bowel Capsule
6.1.3 Colon Capsule
6.1.4 Esophageal Capsule
6.2 Global Capsule Endoscopy Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 Wireless Capsule Endoscopy
6.2.3 Receiver Capsule Endoscopy
6.2.4 Others
6.3 Global Capsule Endoscopy Market (2017-2032) by Component
6.3.1 Market Overview
6.3.2 Camera Capsule
6.3.3 Workstation
6.3.4 Data Recorder
6.4 Global Capsule Endoscopy Market (2017-2032) by Application
6.4.1 Market Overview
6.4.2 Intestine Disease
6.4.3 Crohn’s Disease
6.4.4 Gastrointestinal Bleeding
6.4.5 Tumours
6.4.6 Others
6.5 Global Capsule Endoscopy Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Diagnostic Laboratories
6.5.4 Ambulatory Surgery Centres
6.5.5 Others
6.6 Global Capsule Endoscopy Market (2017-2032) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Capsule Endoscopy Market (2017-2032)
7.1 North America Capsule Endoscopy Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Small Bowel Capsule
7.1.3 Colon Capsule
7.1.4 Esophageal Capsule
7.2 North America Capsule Endoscopy Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 Wireless Capsule Endoscopy
7.2.3 Receiver Capsule Endoscopy
7.2.4 Others
7.3 North Capsule Endoscopy Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Capsule Endoscopy Market (2017-2032)
8.1 Europe Capsule Endoscopy Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Small Bowel Capsule
8.1.3 Colon Capsule
8.1.4 Esophageal Capsule
8.2 Europe Capsule Endoscopy Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 Wireless Capsule Endoscopy
8.2.3 Receiver Capsule Endoscopy
8.2.4 Others
8.3 Europe Capsule Endoscopy Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Capsule Endoscopy Market (2017-2032)
9.1 Asia Pacific Capsule Endoscopy Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Small Bowel Capsule
9.1.3 Colon Capsule
9.1.4 Esophageal Capsule
9.2 Asia Pacific Capsule Endoscopy Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 Wireless Capsule Endoscopy
9.2.3 Receiver Capsule Endoscopy
9.2.4 Others
9.3 Asia Pacific Capsule Endoscopy Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Capsule Endoscopy Market (2017-2032)
10.1 Latin America Capsule Endoscopy Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Small Bowel Capsule
10.1.3 Colon Capsule
10.1.4 Esophageal Capsule
10.2 Latin America Capsule Endoscopy Market (2017-2032) by Type
10.2.1 Market Overview
10.2.2 Wireless Capsule Endoscopy
10.2.3 Receiver Capsule Endoscopy
10.2.4 Others
10.3 Latin Capsule Endoscopy Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Capsule Endoscopy Market (2017-2032)
11.1 Middle East and Africa Capsule Endoscopy Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Small Bowel Capsule
11.1.3 Colon Capsule
11.1.4 Esophageal Capsule
11.2 Middle East and Africa Capsule Endoscopy Market (2017-2032) by Type
11.2.1 Market Overview
11.2.2 Wireless Capsule Endoscopy
11.2.3 Receiver Capsule Endoscopy
11.2.4 Others
11.3 Middle East and Africa Capsule Endoscopy Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 The Guidant Group
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 CapsoCam Plus
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 ConMed Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 IntroMedic Co., Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 JINSHAN Science & Technology
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medtronic Plc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Olympus Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 RF Co.,Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Fujifilm Holdings Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Check-Cap.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Accu-Read, INC.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Interscope
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Shangxian Minimal Invasive Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Capsule Endoscopy Market (2017-2032) Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 959.60 million in 2023 driven by the rising prevalence of gastrointestinal diseases such as colorectal cancer and Crohn's disease across the globe.
The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032, likely to reach a market value of USD 2,033.10 million by 2032.
Technological advancement in capsule endoscopy and the growing focus of the government to improve healthcare facilities are fuelling the demand for capsule endoscopes.
One of the significant trends in the market is the integration of artificial intelligence in capsule endoscopy technologies to improve patient outcomes. In July 2023 , Sheba Medical Center (Israel) entered a strategic partnership with Intel to develop an AI algorithm that takes only minutes to analyse the images generated by the capsule endoscope.
Based on the product, the market is segmented into a small bowel capsule, colon capsule, and esophageal capsule.
Based on the components, the market is divided into camera capsule, workstation, and data recorder.
The types of capsule endoscopy available in the market are wireless capsule endoscopy, and receiver capsule endoscopy, among others.
Major end users of capsule endoscopy include hospitals, diagnostic laboratories, and ambulatory surgery centers, among others.
Capsule endoscopy is used in the diagnosis of intestine disease, Crohn's disease, gastrointestinal bleeding, and tumors, among others.
The major regions of the market include North America, Europe, Asia Pacific, and Latin America, Middle East, and Africa.
Key players involved in the market are Boston Scientific Corporation, The Guidant Group, CapsoCam Plus, ConMed Corporation, IntroMedic Co., Ltd., JINSHAN Science & Technology, Medtronic Plc, Olympus Corporation, RF Co., Ltd., Fujifilm Holdings Corporation, Check-Cap., Accu-Read, INC., Interscope, and Shangxian Minimal Invasive Inc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.